Supplementary Table 2.docx (21.63 kB)
Download fileimt-2021-0013 - Supplementary Material - Ruxolitinib, a JAK1/JAK2 selective inhibitor, ameliorates acute and chronic steroid-refractory GvHD mouse models
dataset
posted on 2021-09-08, 10:52 authored by Figshare Future Science GroupFigshare Future Science Group, Eduardo Huarte, Michael Peel, Ashish Juvekar, Philip Dubé, Sarala Sarah, Lynn Stephens, Becky Stewart, Brian Long, Philip Czerniak, Julian Oliver, Paul SmithSupplementary Table 2. Assessment of GvHD
in transplanted mice – modified chronic sclerodermatous GvHD scoring protocol.
